12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Global landscape and genetic regulation of RNA editing in cortical samples from individuals with schizophrenia

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          RNA editing critically regulates neurodevelopment and normal neuronal function. We surveyed RNA editing across 364 schizophrenia cases and 383 control postmortem brain samples from the CommonMind Consortium, comprising two regions: dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex. In schizophrenia, RNA editing sites in genes encoding AMPA-type glutamate receptors and post-synaptic density proteins were less edited, while those encoding translation initiation machinery were more edited. These sites replicate between brain regions, map to 3’UTR and intronic regions, share common sequence motifs, and map to binding sites for RNA binding proteins crucial for neurodevelopment. These findings cross-validate in hundreds of non-overlapping DLPFC samples. Furthermore, ~30% of RNA editing sites associate with cis-regulatory variants (edQTLs). Fine-mapping edQTLs with schizophrenia GWAS loci revealed co-localization of 11 edQTLs with 6 GWAS loci. Our findings demonstrate widespread altered RNA editing in schizophrenia and its genetic regulation, and suggest RNA editing mechanisms of schizophrenia neuropathology.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Schizophrenia: a concise overview of incidence, prevalence, and mortality.

          Recent systematic reviews have encouraged the psychiatric research community to reevaluate the contours of schizophrenia epidemiology. This paper provides a concise overview of three related systematic reviews on the incidence, prevalence, and mortality associated with schizophrenia. The reviews shared key methodological features regarding search strategies, analysis of the distribution of the frequency estimates, and exploration of the influence of key variables (sex, migrant status, urbanicity, secular trend, economic status, and latitude). Contrary to previous interpretations, the incidence of schizophrenia shows prominent variation between sites. The median incidence of schizophrenia was 15.2/100,000 persons, and the central 80% of estimates varied over a fivefold range (7.7-43.0/100,000). The rate ratio for males:females was 1.4:1. Prevalence estimates also show prominent variation. The median lifetime morbid risk for schizophrenia was 7.2/1,000 persons. On the basis of the standardized mortality ratio, people with schizophrenia have a two- to threefold increased risk of dying (median standardized mortality ratio = 2.6 for all-cause mortality), and this differential gap in mortality has increased over recent decades. Compared with native-born individuals, migrants have an increased incidence and prevalence of schizophrenia. Exposures related to urbanicity, economic status, and latitude are also associated with various frequency measures. In conclusion, the epidemiology of schizophrenia is characterized by prominent variability and gradients that can help guide future research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia

            The pathophysiological characteristics of schizophrenia appear to involve altered synaptic connectivity in the dorsolateral prefrontal cortex. Given the central role that layer 3 pyramidal neurons play in corticocortical and thalamocortical connectivity, we hypothesized that the excitatory inputs to these neurons are altered in subjects with schizophrenia.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              RADAR: a rigorously annotated database of A-to-I RNA editing

              We present RADAR—a rigorously annotated database of A-to-I RNA editing (available at http://RNAedit.com). The identification of A-to-I RNA editing sites has been dramatically accelerated in the past few years by high-throughput RNA sequencing studies. RADAR includes a comprehensive collection of A-to-I RNA editing sites identified in humans (Homo sapiens), mice (Mus musculus) and flies (Drosophila melanogaster), together with extensive manually curated annotations for each editing site. RADAR also includes an expandable listing of tissue-specific editing levels for each editing site, which will facilitate the assignment of biological functions to specific editing sites.
                Bookmark

                Author and article information

                Journal
                9809671
                21092
                Nat Neurosci
                Nat. Neurosci.
                Nature neuroscience
                1097-6256
                1546-1726
                26 July 2019
                27 August 2019
                September 2019
                27 February 2020
                : 22
                : 9
                : 1402-1412
                Affiliations
                [1 ]Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [2 ]Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [3 ]Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [4 ]Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [5 ]The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [6 ]Department of Genetics, Stanford University School of Medicine, Stanford, California, 94305, USA
                [7 ]Pamela Sklar Division of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [8 ]Mental Illness Research, Education, and Clinical Center (VISN 2 South), James J. Peters VA Medical Center, Bronx, New York, 10468, USA
                [9 ]Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [10 ]Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142 USA
                [11 ]Department of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                [12 ]Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O’Hara Street, Pittsburgh, Pennsylvania 15213, USA
                [13 ]Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029 USA
                Author notes
                [14]

                A full list of authors can be found at the end of the article.

                AUTHOR CONTRIBUTIONS

                J.D.B., P.S., J.B.L. and M.S.B contributed to experimental design, study design and formulating the research question. J.D.B. and P.S. contributed the funding of this work. M.S.B., A.D., and Q.L. contributed to data analysis. P.R., G.E.H., E.S., A.C, P.S., B.D. and J.D.B. contributed to leadership and supervision of various aspects of this work. M.S.B. and J.D.B. contributed to writing the manuscript and all authors contributed to completing the final version.

                [* ] Correspondence to: Michael S. Breen ( michael.breen@ 123456mssm.edu ), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Annenberg Building 22-38, New York, NY 10029; Joseph D. Buxbuam ( joseph.buxbaum@ 123456mssm.edu ), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Annenberg Building 22-38, New York, NY 10029
                Author information
                http://orcid.org/0000-0002-6739-939X
                http://orcid.org/0000-0001-8898-8313
                Article
                NIHMS1534157
                10.1038/s41593-019-0463-7
                6791127
                31455887
                28737a3c-ca24-4259-884d-0fd9c387700b

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Neurosciences
                rna editing quantitative trait loci,disease risk,molecular mechanisms,neurodevelopment

                Comments

                Comment on this article